Non-pharmacological aspects of blood pressure management: What are the data

Kidney International

Volumn 79, Issue 10, 2011, Pages 1061-1070

  Hedayati, S Susan ^a,b   Elsayed, Essam F ^a,b   Reilly, Robert F ^a,b,c  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

blood pressure; DASH diet; hypertension; lifestyle modification

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; CALCIUM; CITRATE POTASSIUM; MAGNESIUM; MAGNESIUM OXIDE; PLACEBO; POTASSIUM; POTASSIUM BICARBONATE; POTASSIUM CHLORIDE; SODIUM;

ALCOHOL CONSUMPTION; BLOOD PRESSURE REGULATION; CALCIUM INTAKE; CARBOHYDRATE DIET; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DIET THERAPY; DIETARY INTAKE; DRUG DOSE COMPARISON; EXERCISE; FAT INTAKE; FRUIT; GENE; GENE EXPRESSION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MAGNESIUM DEFICIENCY; MAGNESIUM INTAKE; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN DIET; REVIEW; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT INDICATION; VEGETABLE; WEIGHT REDUCTION; WNK1 GENE;

EID: 79955575806     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.46     Document Type: Review

References (137)

1. Ostchega Y, Yoon SS, Hughes J et al. Hypertension Awareness, Treatment, and Control-Continued Disparities in Adults: United States, 2005-2006. NCHS data brief no. 3. National Center for Health Statistics: Hyattsville, MD, 2008 Available at http://www.cdc.gov/nchs/data/databriefs/db03. pdf.
2. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)
3. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598-615. (Pubitemid 23072389)
4. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
5. Hsu CY, McCulloch CE, Darbinian J et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005; 165: 923-928. (Pubitemid 40563240)
6. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18. (Pubitemid 26012498)
7. Wang JG, Staessen JA, Franklin SS et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45: 907-913. (Pubitemid 40628936)
8. Lewington S, Clarke R, Qizilbash N et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
9. Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885-892.
10. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 h sodium and potassium excretion. BMJ 1988; 297: 319-328.
11. Carvalho JJ, Baruzzi RG, Howard PF et al. Blood pressure in four remote populations in the INTERSALT Study. Hypertension 1989; 14: 238-246. (Pubitemid 19219999)
12. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a 'no-salt' culture. Circulation 1975; 52: 146-151.
13. Mancilha-Carvalho JJ, de Oliveira R, Esposito RJ. Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. J Hum Hypertens 1989; 3: 309-314. (Pubitemid 19247898)
14. Mancilha-Carvalho JJ, Crew DE. Lipid profiles of Yanomamo Indians of Brazil. Prev Med 1990; 19: 66-75. (Pubitemid 20136919)
15. Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
16. Appel LJ, Sacks FM, Carey VJ et al. Effects of protein, monounsaturated fat and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-2464. (Pubitemid 41627923)
17. Blumenthal JA, Babyak MA, Hinderliter A et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010; 170: 126-135.
18. Kumanyika SK, Hebert PR, Cutler JA et al. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension 1993; 22: 502-512. (Pubitemid 23292156)
19. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
20. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention, phase I. JAMA 1992; 267: 1213-1220.
21. He J, Whelton PK, Lawrence JA et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544-549. (Pubitemid 30108146)
22. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure: the trials of hypertension prevention, phase II. Arch Intern Med 1997; 157: 657-667.
23. Miller III ER, Erlinger TP, Young DR. Results of the diet, exercise, and Weight LOSS Intervention Trial (DEW-IT). Hypertension 2002; 40: 612-618. (Pubitemid 35278595)
24. Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083-2093.
25. Pickering TG. Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA 2003; 289: 2131-2132. (Pubitemid 37430216)
26. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989; 320: 1177-1182. (Pubitemid 19124299)
27. Morris Jr RC, Sebastian A, Forman A et al. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33: 18-23. (Pubitemid 29061836)
28. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA 1977; 237: 2385-2391.
29. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary References Intakes. Institutes of medicine of the national academies. Dietary references intakes for water, potassium, sodium, chloride, and sulfate. Natl Acad Press 2004; 25: 186-268.
30. Kizer JR, Arnett DK, Bella JN et al. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 2004; 43: 1182-1188. (Pubitemid 38691738)
31. Klag MJ, Whelton PK, Randall BL et al. End-stage renal disease in African- American and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293-1298. (Pubitemid 27194353)
32. Kittner SJ, White LR, Losonczy KG et al. Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA 1990; 264: 1267-1270. (Pubitemid 20285957)
33. Huang CL, Kuo E. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nature Clin Prac Nephrol 2007; 3: 623-630. (Pubitemid 350012824)
34. Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 1986; 8: 93-102. (Pubitemid 16105215)
35. Wilson FH, Disse-Nicodème S, Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112. (Pubitemid 32758085)
36. Xu BE, Stippec S, Chu PY et al. WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 2005; 102: 10315-10320. (Pubitemid 41023368)
37. Yang CL, Angell J, Mitchell R et al. WNK kinases regulate thiazidesensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045. (Pubitemid 36397480)
38. Yang CL, Zhu X, Ellison DH. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007; 117: 3403-3411. (Pubitemid 350096996)
39. Lazrak A, Liu Z, Huang CL. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci USA 2006; 103: 1615-1620. (Pubitemid 43191213)
40. Skrabal F, Aubock J, Hortnagl H. Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet 1981; 1: 895-900. (Pubitemid 11008429)
41. MacGregor GA, Smith SJ, Markandu ND et al. Moderate potassium supplementation in essential hypertension. Lancet 1982; 320: 567-570. (Pubitemid 12049484)
42. Khaw KT, Thom S. Randomized double-blind cross-over trial of potassium on blood pressure in normal subjects. Lancet 1982; 320: 1127-1129. (Pubitemid 13232060)
43. Kaplan NM, Carnegie A, Raskin P et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 1985; 312: 746-749. (Pubitemid 15104795)
44. Matlou SM, Isles CG, Higgs A et al. Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens 1986; 4: 61-64. (Pubitemid 16129685)
45. Chalmers J, Morgan T, Doyle A et al. Australian National Health and Medical Research Council Dietary Salt Study in mild hypertension. J Hypertens 1986; 4(Suppl 6): S629-S637.
46. Siani A, Strazzullo P, Russo L et al. Controlled trial of long-term oral potassium supplements in patients with mild hypertension. BMJ 1987; 294: 1453-1456. (Pubitemid 17079621)
47. Svetkey LP, Yarger WE, Feussner JR et al. Double-blind, placebocontrolled trial of potassium chloride in the treatment of mild hypertension. Hypertension 1987; 9: 444-450. (Pubitemid 17068760)
48. Obel AO. Placebo-controlled trial of potassium supplements in black patients with mild essential hypertension. J Cardiovasc Pharmacol 1989; 14: 294-296. (Pubitemid 19189511)
49. Patki PS, Singh J, Gokhale SV et al. Efficacy of potassium and magnesium in essential hypertension: a double blind, placebo controlled, crossover study. BMJ 1990; 301: 521-523. (Pubitemid 20320922)
50. Valdes G, Vio CP, Montero J et al. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J Hum Hypertens 1991; 5: 91-96.
51. Overlack A, Conrad H, Stumpe KO. The influence of oral potassium citrate/bicarbonate on blood pressure in essential hypertension during unrestricted salt intake. Klin Wochenschr 1991; 69: 79-83.
52. Fotherby MD, Potter JF. Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens 1992; 10: 1403-1408.
53. Brancati FL, Appel LJ, Seidler AJ et al. Potassium supplementation reduces blood pressure in African Americans. Arch Intern Med 1996; 156: 61-67.
54. Richards AM, Nicholls MG, Espiner EA et al. Blood pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet 1984; 1: 757-761.
55. Smith SJ, Markandu ND, Sagnella GA et al. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? BMJ 1985; 290: 110-113. (Pubitemid 15122948)
56. Zoccali C, Cumming AMM, Hutcheson MJ et al. Effects of potassium on sodium balance, renin, noradrenalin and arterial pressure. J Hypertens 1985; 3: 67-72. (Pubitemid 15075041)
57. Bulpitt CJ, Ferrier G, Lewis PJ et al. Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. Ann Clin Res 1985; 17: 126-130. (Pubitemid 15248285)
58. Barden AE, Vandongen R, Beilin LJ et al. Potassium supplementation does not lower blood pressure in normotensive women. J Hypertens 1986; 4: 339-343. (Pubitemid 16000989)
59. Poulter NR, Sever PS. Moderate potassium supplementation: ineffective in black normotensives. East Afr Med J 1986; 63: 798-802.
60. Grobbee DE, Hofman A, Roelandt JT et al. Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure. J Hypertens 1987; 5: 115-119. (Pubitemid 17058042)
61. Medical Research Council Working Party. Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: sub-studies of the Medical Research Council's Trials of Treatment of Mild Hypertension. J Clin Pharmacol 1987; 27: 271-277.
62. Grimm RH, Kofron PM, Neaton JD et al. Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication. J Hypertens 1988; 6(Suppl 4): S591-S593. (Pubitemid 19067414)
63. Cushman WC, Langford HG. Randomized controlled trial of potassium chloride versus placebo in mildly hypertensive blacks and whites [abstract]. Circulation 1988; 78: II-370.
64. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150: 153-162.
65. Mullen JT, O'Connor DT. Potassium effects on blood pressure: is the conjugate anion important? J Hum Hypertens 1990; 4: 589-596.
66. Barden A, Beilin LJ, Vandongen R et al. A double-blind placebocontrolled trial of the effects of short-term potassium supplementation on blood pressure and atrial natriuretic peptide in normotensive women. Am J Hypertens 1991; 4: 206-213.
67. Smith SR, Klotman PE, Svetkey LP. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol 1992; 2: 1302-1309.
68. Whelton PK, Buring J, Borhani NO, et al., for the Trials of Hypertension Prevention (TOHP) Collaborative Research Group. The effect of potassium supplementation in persons with a high-normal blood pressure: results from phase I of the Trials of Hypertension Prevention. Ann Epidemiol 1995; 5: 85-95.
69. Grimm Jr RH, Neaton JD, Elmer PJ et al. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med 1990; 322: 569-574. (Pubitemid 20190790)
70. Whelton PK, He J, Cutler JA et al. Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624-1632. (Pubitemid 27231195)
71. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomized trials. J Hum Hypertens 2003; 17: 471-480. (Pubitemid 36903334)
72. Mullen JT, O'Connor DT. Potassium effects on blood pressure: is the conjugate anion important? J Hum Hypertens 1990; 4: 589-596.
73. Overlack A, Conrad H, Stumpe KO. The influence of oral potassium citrate/bicarbonate on blood pressure in essential hypertension during unrestricted salt intake. Klin Wochenschr 1991; 69(Suppl 25): 79-83.
74. Van Buren M, Rabelink TJ, Van Rijn HJM et al. Effects of acute NaCl, KCl and KHCO3 loads on renal electrolyte excretion in humans. Clin Sci 1992; 83: 567-574.
75. Schmidlin O, Forman A, Tanaka M et al. NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension 1999; 33: 633-639. (Pubitemid 29091639)
76. Morris Jr RC, Schmidlin O, Tanaka M et al. Differing effects of supplemental KCl and KHCO3: pathophysiological and clinical implications. Semin Nephrol 1999; 19: 487-493. (Pubitemid 29451202)
77. He FJ, Markandu ND, Coltart R et al. Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension 2005; 45: 571-574. (Pubitemid 40411261)
78. Overlack A, Maus B, Ruppert M et al. [Potassium citrate versus potassium chloride in essential hypertension. Effects on hemodynamic, hormonal and metabolic parameters]. Dtsch Med Wochenschr 1995; 120: 631-635.
79. Witteman JC, Willett WC, Stampfer MJ et al. A prospective study of nutritional factors and hypertension among US women. Circulation 1989; 80: 1320-1327. (Pubitemid 19282522)
80. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr 1987; 45: 469-475. (Pubitemid 17020815)
81. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) 1983; 286: 1847-1849. (Pubitemid 13100164)
82. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13: 227-232. (Pubitemid 19083693)
83. Widman L, Wester PO, Stegmayr BK et al. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 1993; 6: 41-45. (Pubitemid 23055803)
84. Ferrara LA, Iannuzzi R, Castaldo A et al. Long-term magnesium supplementation in essential hypertension. Cardiology 1992; 81: 25-33.
85. Cappuccio FP, Markandu ND, Beynon GW et al. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) 1985; 291: 235-238. (Pubitemid 15045050)
86. Lind L, Lithell H, Pollare T et al. Blood pressure response during longterm treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens 1991; 4: 674-679.
87. Kawano Y, Matsuoka H, Takishita S et al. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension 1998; 32: 260-265. (Pubitemid 28376482)
88. Jee SH, Miller III ER, Guallar E et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15: 691-696. (Pubitemid 34804274)
89. Park J, Lee JS, Kim J. Relationship between dietary sodium, potassium, and calcium, anthropometric indexes, and blood pressure in young and middle aged Korean adults. Nutr Res Pract 2010; 4: 155-162.
90. van Mierlo LA, Arends LR, Streppel M et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006; 20: 571-580. (Pubitemid 44088959)
91. Dickinson HO, Nicolson DJ, Cook JV et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006; 2: CD004639.
92. Hofmeyr GJ, Lawrie TA, Atallah AN et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010; 8: CD001059.
93. Saito I, Nomura M, Hiurose H et al. Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan. Clin Exp Hypertens 2010; 32: 210-213.
94. Richter CM, Panigas TF, Bundchen DC et al. Blood pressure reduction in hyper-reactive individuals after aerobic exercise. Arq Bras Cardiol 2010; 95: 251-257.
95. Whelton SP, Chin A, Xin X et al. Effects of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503. (Pubitemid 34252283)
96. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2000; 35: 838-843. (Pubitemid 30165335)
97. Belles DR. The Benefits of Circuit Weight Training in Law Enforcement Personnel [dissertation]. University of Florida: Gainesville, Fla, 1989.
98. Blumenthal JA, Siegal WC, Appelbaum M. Failure of exercise to reduce blood pressure in patients with mild hypertension. JAMA 1991; 266: 2098-2104.
99. Byrne HK. The Effects of Exercise Training on Resting Metabolic Rate and Resting Blood Pressure in Women [dissertation]. University of Texas at Austin: Austin, Tex, 1997.
100. Cononie CC, Graves JE, Pollock ML et al. Effect of exercise training on blood pressure in 70- to 79-yr-old men and women. Med Sci Sports Exerc 1991; 23: 505-511.
101. Don BWM. The Effects of Strength Training on Cardiovascular Reactivity to Stress and Psychological Well-Being in College Women [dissertation]. Boston University: Boston, Mass, 1996.
102. Dunstan DW, Puddey IB, Beilin LJ et al. Effects of a short-term circuit weight training program on glycaemic control in NIDDM. Diabetes Res Clin Pract 1998; 40: 53-61. (Pubitemid 28337798)
103. Harris KA, Holly RG. Physiological response to circuit weight training in borderline hypertensive subjects. Med Sci Sports Exerc 1987; 19: 246-252. (Pubitemid 17110080)
104. Katz J, Wilson BRA. The effects of a six-week, low intensity Nautilus circuit training program on resting blood pressure in females. J Sports Med Phys Fitness 1992; 32: 299-302. (Pubitemid 23020635)
105. Moul J. The Effects of 16-Week Walking and 16-Week Weight-Training Programs on the Performance of Men and Women Ages 65-77 on the Ross Information Processing Assessment [dissertation]. University of North Carolina at Greensboro: Greensboro, NC, 1993.
106. Tsutsumi T. The Effects of Strength Training on Mood, Self-Efficacy, Cardiovascular Reactivity and Quality of Life in Older Adults [dissertation]. Boston University: Boston, Mass, 1997.
107. Van Hoof R, Macor F, Lijnen P et al. Effect of strength training on blood pressure measured at various conditions in sedentary men. Int J Sports Med 1996; 17: 415-422. (Pubitemid 26317135)
108. Zago AS, Reis Silveira L, Kokubun E. Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in prehypertensive older people. Eur J Appl Physiol 2010; 110: 825-832.
109. Seals DR, Reiling MJ. Effect of regular exercise on 24-h arterial pressure in older hypertensive humans. Hypertension 1991; 18: 583-592.
110. Van Hoof R, Hespel P, Fagard R et al. Effect of endurance training on blood pressure at rest, during exercise and during 24 h in sedentary men. Am J Cardiol 1989; 63: 945-949. (Pubitemid 19105131)
111. Vriz O, Mos L, Frigo G et al. Effects of physical exercise on clinic and 24-h ambulatory blood pressure in young subjects with mild hypertension. J Sports Med Phys Fitness 2002; 42: 83-88. (Pubitemid 34288468)
112. Gilders RM, Voner C, Dudley GA. Endurance training and blood pressure in normotensive and hypertensive adults. Med Sci Sports Exerc 1989; 21: 629-636. (Pubitemid 20022146)
113. Pescatello LS, Kulikowich JM. The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc 2001; 33: 1855-1861. (Pubitemid 33035480)
114. Abramson JL, Lewis C, Murrah NV. Relationship of self-reported alcohol consumption to ambulatory blood pressure in a sample of healthy adults. Am J Hypertens 2010; 23: 994-999.
115. Ohira T, Tanigawa Tabata M et al. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 2009; 53: 13-19.
116. Potter JF, Beevers DG. Pressor effect of alcohol in hypertension. Lancet 1984; 1: 119-122. (Pubitemid 14217547)
117. Puddey IB, Beilin LJ, Vandongen R et al. Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men, a randomized controlled trial. Hypertension 1985; 7: 707-713. (Pubitemid 15238768)
118. Howes LG, Reid JL. Changes in blood pressure and autonomic reflexes following regular, moderate alcohol consumption. J Hypertens 1986; 4: 421-425. (Pubitemid 17001470)
119. Puddey IB, Beilin LJ, Vandongen R. Effect of regular alcohol use on blood pressure control in treated hypertensive subjects: a controlled study. Clin Exp Pharmacol Physio 1986; 13: 315-318. (Pubitemid 16096950)
120. Ueshima H, Ogihara T, Baba S et al. The effect of reduced alcohol consumption on blood pressure: a randomized controlled single blind study. J Hum Hypertens 1987; 1: 113-119. (Pubitemid 18075133)
121. Wallace P, Cutler S, Haines A. Randomized controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ 1988; 297: 663-668.
122. Parker M, Puddey IB, Beilin LJ et al. Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension 1990; 16: 398-406. (Pubitemid 20338533)
123. Maheswaran R, Beevers M, Beevers DG. Effectiveness of advice to reduce alcohol consumption in hypertensive patients. Hypertension 1992; 19: 79-84.
124. Puddey IB, Parker M, Beilin LJ et al. Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. Hypertension 1992; 20: 533-541.
125. Cox KL, Puddey IB, Morton AR et al. The combined effects of aerobic exercise and alcohol restriction on blood pressure and serum lipids: a twoway factorial study in sedentary men. J Hypertens 1993; 11: 191-201. (Pubitemid 23130573)
126. Ueshima H, Mikawa K, Baba S et al. Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension 1993; 21: 248-252. (Pubitemid 23035079)
127. Lang T, Nicaud V, Lang T et al. Improving hypertension control among excessive alcohol drinkers: randomized controlled trial in France. J Epidemiol Commun Health 1995; 49: 610-616. (Pubitemid 26013724)
128. Kawano Y, Abe H, Takishita S et al. Effects of alcohol restriction on 24-h ambulatory blood pressure in Japanese men with hypertension. Am J Med 1998; 105: 307-311. (Pubitemid 28487539)
129. Rakic V, Puddey IB, Burke V et al. Influence of pattern of alcohol intake on blood pressure in regular drinkers: a controlled trial. J Hypertens 1998; 16: 165-174. (Pubitemid 28088862)
130. Cushman WC, Cutler JA, Hanna E et al. Prevention And Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med 1998; 158: 1197-1207. (Pubitemid 28252483)
131. Xin X, He J, Frontini MG. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001; 38: 1112-1117. (Pubitemid 34252815)
132. Pimenta E, Oparil S. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol 2009; 6: 21-30.
133. Appel LJ, Brands DW, Daniels SR et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47: 296-308. (Pubitemid 43189776)
134. Mattes RD, Donnelly BS. Relative contributions of dietary sodium sources. J Amer Coll Nutr 1991; 10: 383-393.
135. Smith-Spangler CM, Juusola JL, Enns EA et al. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med 2010; 152: 481-487.
136. Johnson RJ, Herrera-Acosta J, Schreiner GF et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346: 913-923. (Pubitemid 34984641)
137. Levey AS, Greene T, Beck GJ et al. Modification of Diet in Renal Disease Study group. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 1999; 10: 2426-2439. (Pubitemid 29501478)